| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690729 | Gynecologic Oncology | 2016 | 6 Pages |
Abstract
Adjuvant RT was not found to be associated with a survival benefit in patients with stage I and II ovarian clear cell carcinoma or in a high risk subset of patients including stage IC cytology positive/surface involvement and stage II patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Liat Hogen, Gillian Thomas, Marcus Bernardini, Dina Bassiouny, Harinder Brar, Lilian T. Gien, Barry Rosen, Lisa Le, Danielle Vicus,